Washington HB 1675: Exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act.

Status: Prefiled for introduction. (as of 2022-12-20)

State: Washington · Session: 2021-2022 · Bill: HB 1675

Subjects: DRUGS, HEALTH AND SAFETY, PUBLIC, HEALTH CARE, MANUFACTURING AND TECHNOLOGY, PHARMACIES AND PHARMACISTS, PUBLIC ASSISTANCE

Sponsors: Bateman, Cody, Dolan, Graham, Griffey, Leavitt, Maycumber, Riccelli

View Washington HB 1675 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.